NCT06102889View on ClinicalTrials.gov

GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE BY LIQUID BIOPSIES

Enrolling by invitationOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

May 2, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Pancreatic Adenocarcinoma
Interventions
DIAGNOSTIC_TEST

liquid biopsy

Taking blood samples (liquid biopsy) for multiple analysis in genomics, proteomics, and metabolomics

Trial Locations (1)

14186

Gastrocentrum, KarolinskaUniversity Hospital, Stockholm

All Listed Sponsors
collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

collaborator

Aarhus University Hospital

OTHER

collaborator

Centre Hospitalier Universitaire de Nice

OTHER

collaborator

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

OTHER

collaborator

Medical University of Graz

OTHER

collaborator

Centre Hospitalier Régional Universitaire Montpellier

OTHER

lead

Karolinska University Hospital

OTHER